Studies on the Balance between Thrombomodulin and HMGB1 in Sepsis Patients
Background: In sepsis patients, the equilibrium between high mobility group box 1 (HMGB1) and thrombomodulin (TM) must be understood. The molecule HMGB1 has been linked to severe sepsis outcomes, and thrombomodulin (TM) appears to have an anti-inflammatory impact. The goal